ES428906A1 - Procedimiento de preparacion de nuevos derivados de 2-ben- zamido-5-nitrotiazol. - Google Patents

Procedimiento de preparacion de nuevos derivados de 2-ben- zamido-5-nitrotiazol.

Info

Publication number
ES428906A1
ES428906A1 ES428906A ES428906A ES428906A1 ES 428906 A1 ES428906 A1 ES 428906A1 ES 428906 A ES428906 A ES 428906A ES 428906 A ES428906 A ES 428906A ES 428906 A1 ES428906 A1 ES 428906A1
Authority
ES
Spain
Prior art keywords
benzamido
new derivatives
thiazoles
nitro
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES428906A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phavic Sprl
Original Assignee
Phavic Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phavic Sprl filed Critical Phavic Sprl
Publication of ES428906A1 publication Critical patent/ES428906A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/58—Nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES428906A 1973-08-08 1974-08-02 Procedimiento de preparacion de nuevos derivados de 2-ben- zamido-5-nitrotiazol. Expired ES428906A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3760873A GB1437800A (en) 1973-08-08 1973-08-08 Derivatives of 2-benzamido-5-nitro-thiazoles

Publications (1)

Publication Number Publication Date
ES428906A1 true ES428906A1 (es) 1976-08-16

Family

ID=10397712

Family Applications (1)

Application Number Title Priority Date Filing Date
ES428906A Expired ES428906A1 (es) 1973-08-08 1974-08-02 Procedimiento de preparacion de nuevos derivados de 2-ben- zamido-5-nitrotiazol.

Country Status (14)

Country Link
US (1) US3950351A (es)
JP (1) JPS5041858A (es)
AR (1) AR201880A1 (es)
BE (1) BE817878A (es)
CA (1) CA1041519A (es)
CH (1) CH583215A5 (es)
DE (1) DE2438037C2 (es)
ES (1) ES428906A1 (es)
FR (1) FR2240010B1 (es)
GB (1) GB1437800A (es)
IL (1) IL45194A (es)
NL (1) NL176779C (es)
OA (1) OA04761A (es)
ZA (1) ZA744409B (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2435905A1 (fr) * 1978-09-13 1980-04-11 Anvar Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
BR8008393A (pt) * 1979-12-21 1981-07-07 Wellcome Found Processo para formar novos compostos heterociclicos
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
NZ284800A (en) * 1994-04-13 1998-02-26 Rossignol Jean Francois 2-hydroxy-n-(5-nitro-thiazol-2-yl)-benzamide, medicaments particularly in conjunction with the acetylated form
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives
US5859038A (en) * 1994-09-08 1999-01-12 Romark Laboratories, L.C. Method for treatment of helicobacter pylori infections
US5968961A (en) 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
MX9604483A (es) * 1994-09-08 1998-02-28 Jean-Francois Rossignol Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
EA002920B1 (ru) * 1997-05-07 2002-10-31 Ромарк Лабораториз Л.С. Фармацевтические композиции на основе тизоксанида и нитазоксанида
AU756451B2 (en) * 1997-05-07 2003-01-16 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
US5935591A (en) * 1998-01-15 1999-08-10 Romark Laboratories, L.C. Method for treatment of equine protozoal myeloencephalitis with thiazolides
US5925622A (en) * 1998-07-13 1999-07-20 Romark Laboratories, L.C. Synthesis of aryl glucuronide of 2-hydroxy-N- (5-nitro-2-thiazolyl) benzamide, and pharmaceutical compositions comprising same
SE0102764D0 (sv) * 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
US7125568B2 (en) * 2001-08-23 2006-10-24 Sung Michael T Lipophilic drug compositions
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
GB0325402D0 (en) * 2003-10-31 2003-12-03 Astrazeneca Ab Compounds
GB0327761D0 (en) * 2003-11-29 2003-12-31 Astrazeneca Ab Compounds
GB0328178D0 (en) * 2003-12-05 2004-01-07 Astrazeneca Ab Compounds
BRPI0507746A (pt) * 2004-02-18 2007-07-10 Astrazeneca Ab composto ou um sal, pró-droga ou solvato do mesmo, composição farmacêutica, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto
WO2005080360A1 (en) * 2004-02-18 2005-09-01 Astrazeneca Ab Compounds
TW200600086A (en) * 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
UA90864C2 (en) * 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
US20060194853A1 (en) * 2004-10-08 2006-08-31 Rossignol Jean F Alkyl benzamides
GB0423044D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
EP1802570A1 (en) 2004-10-16 2007-07-04 AstraZeneca AB Process for making phenoxy benzamide compounds
GB0423043D0 (en) * 2004-10-16 2004-11-17 Astrazeneca Ab Compounds
US20070015803A1 (en) * 2005-04-12 2007-01-18 Romark Laboratories L.C. Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
WO2006125958A1 (en) * 2005-05-24 2006-11-30 Astrazeneca Ab 2-phenyl substituted imidazol [4 , 5b] pyridine/ pyrazine and purine derivatives as glucokinase modulators
TW200714597A (en) * 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
ES2397648T3 (es) * 2005-07-09 2013-03-08 Astrazeneca Ab Derivados de heteroarilbenzamida para uso como activadores de GLK en el tratamiento de la diabetes
US20080234273A1 (en) * 2005-07-09 2008-09-25 Mckerrecher Darren Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
JP2009500442A (ja) * 2005-07-09 2009-01-08 アストラゼネカ アクチボラグ ２型糖尿病を処置するためのグルコキナーゼのモジュレーターとしての２−ヘテロシクリルオキシベンゾイルアミノヘテロシクリル化合物
US9202182B2 (en) * 2005-08-11 2015-12-01 International Business Machines Corporation Method and system for analyzing business architecture
TW200738621A (en) * 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
US8633230B2 (en) 2006-01-09 2014-01-21 Jean-Francois Rossignol Viral hepatitis treatment
WO2008008480A2 (en) * 2006-07-12 2008-01-17 Cumbre Pharmaceuticals Inc. Nitroheteroaryl-containing rifamycin derivatives
CN100465169C (zh) * 2006-08-02 2009-03-04 杭州欣阳三友精细化工有限公司 硝唑尼特的制备方法
TW200825063A (en) * 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
SA07280576B1 (ar) * 2006-10-26 2011-06-22 استرازينيكا ايه بي مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز
CN101595104A (zh) * 2006-12-21 2009-12-02 阿斯利康(瑞典)有限公司 作为glk活化剂的新的晶态化合物
CN101007792B (zh) * 2007-01-31 2010-05-26 浙江大学 一种合成硝基噻唑苯酰胺化合物的方法
PT2178852E (pt) * 2007-08-03 2015-11-12 Romark Lab Lc Compostos tiazolida substituídos com alquilsulfonilo
AU2009278929B2 (en) * 2008-08-04 2012-07-05 Astrazeneca Ab Pyrazolo [3,4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity
WO2010077613A1 (en) 2008-12-09 2010-07-08 Gilead Sciences, Inc. Modulators of toll-like receptors
PL2395840T3 (pl) 2009-02-13 2020-09-07 Romark Laboratories, L.C. Preparaty farmaceutyczne nitazoksanidu o kontrolowanym uwalnianiu
GB0902434D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
GB0902406D0 (en) * 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
WO2010116176A1 (en) * 2009-04-09 2010-10-14 Astrazeneca Ab Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity
WO2010116177A1 (en) 2009-04-09 2010-10-14 Astrazeneca Ab A pyrazolo [4,5-e] pyrimidine derivative and its use to treat diabetes and obesity
PE20121118A1 (es) * 2009-05-12 2012-09-05 Romark Lab Lc Compuestos de haloalquil heteroaril benzamida
CN102480967A (zh) 2009-06-26 2012-05-30 罗马克实验室有限公司 用于治疗流感的化合物和方法
CN101602744B (zh) * 2009-06-30 2011-06-01 青岛康地恩药业有限公司 一种硝唑尼特的制备方法
WO2013110975A1 (es) 2012-01-27 2013-08-01 Siegfried Rhein S.A. De C.V. Composición de nitazoxanida mejorada y proceso para prepararla
BR112015006861B1 (pt) 2012-09-27 2021-10-13 Siegfried Rhein S.A. De C.V. Composição farmacêutica sinérgica e processo para preparar a dita composição
EP3010345A4 (en) * 2013-06-21 2017-04-12 The Regents of The University of California Expanded therapeutic potential in nitroheteroaryl antimicrobials
MA40238A (fr) 2014-07-11 2017-05-17 Gilead Sciences Inc Modulateurs de récepteurs de type toll pour le traitement du vih
US9738646B2 (en) 2014-09-16 2017-08-22 Gilead Sciences, Inc. Solid forms of a toll-like receptor modulator
TW201619142A (zh) 2014-11-11 2016-06-01 羅馬克實驗室有限公司 利用替唑尼特（ｔｉｚｏｘａｎｉｄｅ）、其類似物或鹽類之前驅藥的組成物及治療方法
CN105175352A (zh) * 2015-10-27 2015-12-23 杭州澳医保灵药业有限公司 一种硝唑尼特的制备方法
CN106831640A (zh) * 2015-12-03 2017-06-13 江苏正大丰海制药有限公司 一种硝唑尼特晶体的制备方法
WO2017173056A1 (en) 2016-03-31 2017-10-05 Romark Laboratories L.C. Thiazolide compounds for treating viral infections
DK3777855T3 (da) 2016-04-11 2023-01-09 Genfit Fremgangsmåder til behandling af fibrotiske sygdomme
CA3046158A1 (en) 2017-01-27 2018-08-02 Genfit Pharmaceutical compositions for combination therapy
WO2018195035A1 (en) 2017-04-18 2018-10-25 Romark Laboratories L.C. Inhibition of protein disulfide-isomerase a3
US20220193042A1 (en) 2019-04-12 2022-06-23 Genfit Nitazoxanide and thiazolides for use in the treatment of diseases associated with oxidative stress
EP4051257A1 (en) 2019-10-28 2022-09-07 Genfit Combination therapy having antioxydant properties
EP4182304A1 (en) 2020-07-20 2023-05-24 Romark Laboratories, L.C. Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) with ethanolamine, morpholine, propanolamine, piperazine and n-methylpiperazine
CA3189487A1 (en) 2020-08-24 2023-03-03 Jean-Francois Rossignol Use of thiazolides against coronaviruses
CN114044761B (zh) * 2021-02-24 2022-05-17 成都贝诺科成生物科技有限公司 一种新的硝基噻唑衍生物及其应用
WO2022218239A1 (zh) * 2021-04-12 2022-10-20 杜心赟 新型噻唑类化合物及其制备方法和用途
CA3233848A1 (en) 2021-10-05 2023-04-13 Sasidhar Balappa SOMAPPA An improved process for the preparation of nitazoxanide and intermediates thereof
CN116898846A (zh) * 2022-04-12 2023-10-20 成都贝诺科成生物科技有限公司 一种硝基噻唑衍生物在制备抑制幽门螺杆菌的抑菌剂中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA497537A (en) * 1953-11-10 H. Clark Joe 2-substituted amino-5-nitrothiazoles
US2735798A (en) * 1956-02-21 Acyl amevo-nitrothiazole compositions
US2829084A (en) * 1958-04-01 Certain alkyl-n
GB577418A (en) * 1942-04-17 1946-05-17 Sandoz Ltd Process for the preparation of amides of aromatic carboxylic acids
US2401522A (en) * 1942-04-17 1946-06-04 Firm Sandoz Ltd Aromatic carboxylic acid amides and a process for their manufacture
FR1306603A (fr) * 1958-08-14 1962-10-19 Innothera Lab Sa Dérivés thiazoliques et leur procédé de préparation
US3475446A (en) * 1967-06-27 1969-10-28 Parke Davis & Co N-(5-nitro-2-thiazolyl)-cycloalkanecarboxamides

Also Published As

Publication number Publication date
DE2438037C2 (de) 1982-06-09
OA04761A (fr) 1980-08-31
JPS5041858A (es) 1975-04-16
AU7135574A (en) 1976-01-22
BE817878A (fr) 1975-01-20
IL45194A (en) 1977-10-31
CA1041519A (en) 1978-10-31
US3950351A (en) 1976-04-13
ZA744409B (en) 1975-07-30
NL7409321A (nl) 1975-02-11
CH583215A5 (es) 1976-12-31
FR2240010A1 (es) 1975-03-07
NL176779B (nl) 1985-01-02
GB1437800A (en) 1976-06-03
FR2240010B1 (es) 1978-03-24
NL176779C (nl) 1985-06-03
IL45194A0 (en) 1974-10-22
AR201880A1 (es) 1975-04-24
DE2438037A1 (de) 1975-02-20

Similar Documents

Publication Publication Date Title
ES428906A1 (es) Procedimiento de preparacion de nuevos derivados de 2-ben- zamido-5-nitrotiazol.
ES455294A1 (es) Un procedimiento de preparacion de una fenilamidina sustituida.
ES403069A1 (es) Procedimiento de preparacion de derivados del acido fenila-cetico.
ES393496A1 (es) Procedimiento de preparacion de nuevos derivados de la 2-pi-rrolidinonas.
ES450741A1 (es) Procedimiento para preparar derivados de vincamina.
ES336046A1 (es) Procedimiento para la obtencion de derivados carbostirilicos
ES429603A1 (es) Procedimiento para la preparacion de 2-fenoxiacetamido-5- nitrotiazoles.
ES403209A1 (es) Un metodo para la produccion de nuevos derivados de aceto- fenon-oxima.
ES398804A1 (es) Procedimiento para la preparacion de nuevos derivados aci- licos de la digoxina.
ES419450A1 (es) Un procedimiento mejorado de aminacion con intercambio parala preparacion de 2-hidrazinobenzotiazoles.
ES410934A1 (es) Procedimiento para la preparacion de acidos indolcarboxili-cos.
ES394322A1 (es) Procedimiento para la preparacion de 2-bencifenoles susti- tuidos.
ES405859A1 (es) Procedimiento para la preparacion de nuevos derivados del 3-(3 beta-tridigistoxosil-12 beta, 14 beta-dihidroxi-5 beta- androstan-17 beta-il)-acrilonitrilo.
ES408974A1 (es) Procedimiento para la preparacion de nuevos derivados de i-soxazolona.
ES433143A1 (es) Procedimiento para preparar compuestos monoazoicos.
ES417881A1 (es) Procedimiento para la preparacion de nuevos 2-(4-bifenilil)-tetrahidrofuranos.
ES279898A1 (es) Procedimiento para la obtención de (4-alquilo-piperacina)-sulfonamidas
ES401347A1 (es) Procedimiento para la obtencion de derivados de la piridi- na.
ES407018A1 (es) Un procedimiento de preparacion de nuevos tiofosfatos.
ES392410A1 (es) Procedimiento para la preparacion de derivados de nitro-2 benzofuranicos.
ES393339A1 (es) Un procedimiento para la preparacion de derivados de nafto-quinona.
ES397958A1 (es) Procedimiento para la obtencion de derivados de tiazol.
ES427333A1 (es) Un procedimiento para la preparacion de esteres 2,6-dihalo-bencilicos.
ES402551A1 (es) Un procedimiento para la preparacion de derivados de pipe- razina.
ES401239A1 (es) Procedimiento para la obtencion de compuestos heterocicli- cos.